Encompass Health Corporation Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Encompass Health Corporation (EHC) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $200.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-07
- Encompass Health Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $200.00K, a 95.24% decline year-over-year.
- Encompass Health Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Encompass Health Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $1.80M, a 63.64% increase year-over-year.
- Encompass Health Corporation right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $9.90M, a 1314.29% increase year-over-year.
- Encompass Health Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $38.20M, a 43.07% increase from fiscal 2024.
- Encompass Health Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $26.70M, a 1.91% increase from fiscal 2023.
- Encompass Health Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $26.20M, a 46.20% decline from fiscal 2022.
- Encompass Health Corporation right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $48.70M, a 81.04% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $200.00K 10-Q · filed 2026-08-07 | $2.00M derived: sum of 3 quarters · filed 2026-08-07 | $11.90M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-01 | $1.80M derived: sum of 2 quarters · filed 2026-05-01 | $11.70M derived: sum of 3 quarters · filed 2026-05-01 | $15.90M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.70M derived: sum of 2 quarters · filed 2026-02-26 | $15.90M derived: sum of 3 quarters · filed 2026-08-07 | $38.20M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $14.10M derived: sum of 2 quarters · filed 2026-08-07 | $36.40M 10-Q · filed 2025-10-31 | $37.50M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $4.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $26.50M 10-Q · filed 2026-08-07 | $27.60M derived: sum of 3 quarters · filed 2026-08-07 | $28.30M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $22.30M 10-Q · filed 2026-05-01 | $23.40M derived: sum of 2 quarters · filed 2026-05-01 | $24.10M derived: sum of 3 quarters · filed 2026-05-01 | $48.10M derived: sum of 4 quarters · filed 2026-05-01 | |||
| 2024-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.80M derived: sum of 2 quarters · filed 2026-02-26 | $25.80M derived: sum of 3 quarters · filed 2026-02-26 | $26.70M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $24.70M derived: sum of 2 quarters · filed 2025-10-31 | $25.60M 10-Q · filed 2025-10-31 | $43.90M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $24.90M 10-Q · filed 2025-08-06 | $43.20M derived: sum of 3 quarters · filed 2026-02-26 | $43.50M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $900.00K 10-Q · filed 2025-05-01 | $19.20M derived: sum of 2 quarters · filed 2026-02-26 | $19.50M derived: sum of 3 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $18.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $18.60M derived: sum of 2 quarters · filed 2026-02-26 | $26.20M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $7.90M 10-Q · filed 2024-11-01 | |||||
| 2023-06-30 | $7.60M 10-Q · filed 2024-08-06 | ||||||
| 2022-12-31 | $25.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $32.50M derived: sum of 2 quarters · filed 2025-02-28 | $42.80M derived: sum of 3 quarters · filed 2025-02-28 | $48.70M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | $6.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $17.20M derived: sum of 2 quarters · filed 2023-11-01 | $23.10M 10-Q · filed 2023-11-01 | $33.00M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | $10.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $16.20M 10-Q · filed 2023-08-04 | $19.50M 10-Q · filed 2022-08-04 | $26.10M derived: sum of 3 quarters · filed 2024-02-28 | $15.10M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $5.90M 10-Q · filed 2022-05-03 | $15.80M derived: sum of 2 quarters · filed 2024-02-28 | $4.80M derived: sum of 3 quarters · filed 2024-02-28 | $15.40M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $9.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$1.10M derived: sum of 2 quarters · filed 2024-02-28 | $9.50M derived: sum of 3 quarters · filed 2024-02-28 | $26.90M 10-K · filed 2024-02-28 | $51.10M 10-K · filed 2022-02-25 | ||
| 2021-09-30 | -$11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$400.00K derived: sum of 2 quarters · filed 2022-11-02 | $17.00M 10-Q · filed 2022-11-02 | $32.20M 10-Q · filed 2021-11-02 | $22.00M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2021-06-30 | $10.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $28.00M 10-Q · filed 2022-08-04 | $33.00M derived: sum of 3 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $17.40M 10-Q · filed 2022-05-03 | $22.40M derived: sum of 2 quarters · filed 2023-02-27 | |||||
| 2020-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $26.20M 10-K · filed 2023-02-27 | $39.00M 10-K · filed 2021-02-26 | ||||
| 2020-09-30 | $21.20M 10-Q · filed 2021-11-02 | ||||||
| 2019-12-31 | -$11.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $23.70M derived: sum of 2 quarters · filed 2022-02-25 | $38.30M derived: sum of 3 quarters · filed 2022-02-25 | $43.80M 10-K · filed 2022-02-25 | |||
| 2019-09-30 | $35.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $49.90M derived: sum of 2 quarters · filed 2019-10-31 | $55.40M 10-Q · filed 2019-10-31 | ||||
| 2019-06-30 | $14.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $20.10M 10-Q · filed 2019-07-31 | |||||
| 2019-03-31 | $5.50M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |